{"id":407639,"date":"2025-09-26T00:30:00","date_gmt":"2025-09-25T22:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/apolipoproteine-e-et-symptomes-neuropsychiatriques-dans-les-troubles-neurocognitifs\/"},"modified":"2025-09-26T02:00:16","modified_gmt":"2025-09-26T00:00:16","slug":"apolipoproteine-e-et-symptomes-neuropsychiatriques-dans-les-troubles-neurocognitifs","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/apolipoproteine-e-et-symptomes-neuropsychiatriques-dans-les-troubles-neurocognitifs\/","title":{"rendered":"Apolipoprot\u00e9ine E et sympt\u00f4mes neuropsychiatriques dans les troubles neurocognitifs"},"content":{"rendered":"\n

Les sympt\u00f4mes neuropsychiatriques (NPS) tels que la d\u00e9pression, l’anxi\u00e9t\u00e9, l’apathie, les psychoses ou les troubles du comportement font partie des sympt\u00f4mes les plus fr\u00e9quents qui accompagnent les troubles neurocognitifs et influencent le pronostic aussi fortement que les d\u00e9ficits cognitifs. La variante g\u00e9n\u00e9tique de l’apolipoprot\u00e9ine E (APOE) est le principal facteur de risque de la maladie d’Alzheimer, mais elle influence \u00e9galement l’apparition de NPS dans diverses maladies neurod\u00e9g\u00e9n\u00e9ratives. Une revue r\u00e9cente r\u00e9sume les liens d\u00e9montr\u00e9s entre les g\u00e9notypes d’APOE et les sympt\u00f4mes neuropsychiatriques et discute de leur pertinence clinique. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Les sympt\u00f4mes neuropsychiatriques (NPS) tels que la d\u00e9pression, l’anxi\u00e9t\u00e9, l’apathie, les psychoses ou les troubles du comportement font partie des sympt\u00f4mes les plus fr\u00e9quents qui accompagnent les troubles neurocognitifs et……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":407641,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Aper\u00e7u actuel des preuves, des m\u00e9canismes et des implications cliniques ","footnotes":""},"category":[11527,11531,11383,11549],"tags":[84937,84935,40639],"powerkit_post_featured":[],"class_list":["post-407639","post","type-post","status-publish","format-standard","has-post-thumbnail","category-etudes","category-formation-continue","category-neurologie-fr","category-rx-fr","tag-apoe-fr","tag-apolipoproteine-e","tag-nps-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-12 10:16:49","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":407665,"slug":"apolipoproteina-e-e-sintomi-neuropsichiatrici-nei-disturbi-neurocognitivi","post_title":"Apolipoproteina E e sintomi neuropsichiatrici nei disturbi neurocognitivi","href":"https:\/\/medizinonline.com\/it\/apolipoproteina-e-e-sintomi-neuropsichiatrici-nei-disturbi-neurocognitivi\/"},"pt_PT":{"locale":"pt_PT","id":407658,"slug":"apolipoproteina-e-e-sintomas-neuropsiquiatricos-em-perturbacoes-neurocognitivas","post_title":"Apolipoprote\u00edna E e sintomas neuropsiqui\u00e1tricos em perturba\u00e7\u00f5es neurocognitivas","href":"https:\/\/medizinonline.com\/pt-pt\/apolipoproteina-e-e-sintomas-neuropsiquiatricos-em-perturbacoes-neurocognitivas\/"},"es_ES":{"locale":"es_ES","id":407652,"slug":"apolipoproteina-e-y-sintomas-neuropsiquiatricos-en-los-trastornos-neurocognitivos","post_title":"Apolipoprote\u00edna E y s\u00edntomas neuropsiqui\u00e1tricos en los trastornos neurocognitivos","href":"https:\/\/medizinonline.com\/es\/apolipoproteina-e-y-sintomas-neuropsiquiatricos-en-los-trastornos-neurocognitivos\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/407639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=407639"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/407639\/revisions"}],"predecessor-version":[{"id":407643,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/407639\/revisions\/407643"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/407641"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=407639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=407639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=407639"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=407639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}